Recurrent GBM Brain Tumors with Few Mutations Respond Best to Immunotherapy
Updated
Written By
Sarah Avery
Director, Duke Health News Office
Related News
Duke Neurosurgery
Duke University School of Medicine
Related News
Duke Neurosurgery
Duke University School of Medicine